Indian Pharma Industry Should Work For Inventing New Drugs, Dr Abdul Kalam

Peethaambaran Kunnathoor | Pharmabiz.com | December 7, 2012

The Indian pharmaceutical industry should turn their attention to invent new drugs from molecule levels and each manufacturing unit should try to become invention centres, opined Dr APJ Abdul Kalam, former President of India. Inaugurating the 64th Indian Pharmaceutical Congress (IPC) at SRM University at Kattankulathur in Tamil Nadu, the former President said there is vast potential for the Indian pharmaceutical sector which encompasses the industry and the academic institutions. India will become the leader in the world in the production of generics before long, he expressed the hope.

Addressing the gathering, Dr Kalam said one among all the tablets used in any part of the world is an Indian made. It shows that Indian pharmaceutical industry can dominate the global market. For this, the researchers in the pharmaceutical sector should attempt for inventing new drugs by utilizing all the capabilities of the industry and the academia. He advised the captains of the industry to involve the pharmacy academic institutions in the country in the endeavour of drug invention as partner in drug development and clinical research.

Quoting the introduction of the anti-malarial drug ‘Synriam’ by Ranbaxy in collaboration with Department of Science & Technology, Dr Kalam said all the industrial pharmacists and researchers must follow the step taken by Ranbaxy as a model and concentrate on inventing new drugs. According to him if the Indian pharma industry has to keep pace with the changes in the international scenario of customer needs, the pharma industrialists in the country have to take a paradigm shift...